We are live on ! Find out more
RPTX

Repare Therapeutics
RPTX

Delisted

RPTX was delisted on the 27th of January, 2026.

Back to rankings

Fund managers haven’t disclosed any holdings of RPTX yet.

RPTX Hedge Fund Activity: Q1 2026 in Review

0 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q1 2026, worth a combined $0 — down 100% from $65.4M a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of RPTX and 0 opened new positions — a net loss of 45 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BVF Inc, exiting entirely with an estimated $26.9M sold.

  • 0 institutional investors held Repare Therapeutics (RPTX) as of Q1 2026, down from 46 in Q4 2025.
  • Funds reported $0 of Repare Therapeutics stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Repare Therapeutics positions in Q1 2026 and 45 closed out, a net change of -45 holders.
  • The largest Repare Therapeutics seller in Q1 2026 was BVF Inc, an estimated $26.9M sold.

Based on aggregated 13F filings for Q1 2026.